Ketamine on Acute Pain in Females and Males
Mouth and Tooth Diseases, Tooth, Impacted
About this trial
This is an interventional treatment trial for Mouth and Tooth Diseases focused on measuring Wisdom, Tooth, Teeth, Third, Molar
Eligibility Criteria
Inclusion Criteria: Indication for removal of third molar Between 20 and 30 years of age ASA Class 1 Exclusion Criteria: Psychiatric family (father/mother) or own anamnestic history Hypersensitivity towards NSAIDS or other rescue analgesics Verified or suspected pregnancy Lactating females Surgery lasting over 60 min
Sites / Locations
- Department of Oral and Maxillofacial Surgery, Ullevaal University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
Placebo males
Ketamine 0,1 mg/kg males
Ketamine 0,3 mg/kg males
Ketamine 0,5 mg/kg males
Placebo females
Ketamine 0.1 mg/kg females
Ketamine 0,3 mg/kg females
Ketamine 0,5 mg/kg females
Saline physiological placebo males
0,1 mg/kg ketamine males
0,3 mg/kg ketamine males
0,5 mg/kg ketamine males
Saline physiological as placebo females
0,1 mg/kg ketamine females
0,3 mg/kg ketamine females
0,5 mg/kg ketamine females